Insider sale
GRACELL BIOTECHNOLOGIES INC.
$1.17M
205K shares
What this filing means
ORBIMED CAPITAL LLC plans to sell 205K shares of GRACELL BIOTECHNOLOGIES INC. valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2023ACC: 0000947871-23-000681
205K
Shares to sell
$1.17M
Approx. market value
205K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private placement
Cash
10/14/2020
205KTotal acquired205K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/14/2020 | Private placement Cash | 205K | — |
| Total | 205K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
205K
Market value
$1.17M
6/15/2023
Total
Units
205K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2023 | 205K | $1.17M | Nasdaq Stock Market | Planned |
| Total | 205K | $1.17M | ||